These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24498269)

  • 41. Identification of novel pathogenic MSH2 mutation and new DNA repair genes variants: investigation of a Tunisian Lynch syndrome family with discordant twins.
    Jaballah-Gabteni A; Tounsi H; Kabbage M; Hamdi Y; Elouej S; Ben Ayed I; Medhioub M; Mahmoudi M; Dallali H; Yaiche H; Ben Jemii N; Maaloul A; Mezghani N; Abdelhak S; Hamzaoui L; Azzouz M; Boubaker S
    J Transl Med; 2019 Jun; 17(1):212. PubMed ID: 31248416
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased frequency of 20q gain and copy-neutral loss of heterozygosity in mismatch repair proficient familial colorectal carcinomas.
    Middeldorp A; van Eijk R; Oosting J; Forte GI; van Puijenbroek M; van Nieuwenhuizen M; Corver WE; Ruano D; Caldes T; Wijnen J; Morreau H; van Wezel T
    Int J Cancer; 2012 Feb; 130(4):837-46. PubMed ID: 21445971
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multigene Panel Testing Provides a New Perspective on Lynch Syndrome.
    Espenschied CR; LaDuca H; Li S; McFarland R; Gau CL; Hampel H
    J Clin Oncol; 2017 Aug; 35(22):2568-2575. PubMed ID: 28514183
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Three molecular pathways model colorectal carcinogenesis in Lynch syndrome.
    Ahadova A; Gallon R; Gebert J; Ballhausen A; Endris V; Kirchner M; Stenzinger A; Burn J; von Knebel Doeberitz M; Bläker H; Kloor M
    Int J Cancer; 2018 Jul; 143(1):139-150. PubMed ID: 29424427
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of mismatch repair gene mutations in Turkish HNPCC patients.
    Tunca B; Pedroni M; Cecener G; Egeli U; Borsi E; Zorluoglu A; Di Gregorio C; Yilmazlar T; Yerci O; de Leon MP
    Fam Cancer; 2010 Sep; 9(3):365-76. PubMed ID: 20373145
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The mechanism of mismatch repair and the functional analysis of mismatch repair defects in Lynch syndrome.
    Martín-López JV; Fishel R
    Fam Cancer; 2013 Jun; 12(2):159-68. PubMed ID: 23572416
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A population-based study of hereditary non-polyposis colorectal cancer: evidence of pathologic and genetic heterogeneity.
    Warden G; Harnett D; Green J; Wish T; Woods MO; Green R; Dicks E; Rahman P; Zhai G; Parfrey P
    Clin Genet; 2013 Dec; 84(6):522-30. PubMed ID: 23278430
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registry.
    Casey MJ; Bewtra C; Lynch HT; Snyder C; Stacy M; Watson P
    Fam Cancer; 2013 Dec; 12(4):719-40. PubMed ID: 23666231
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of yield and experiences of age-related molecular investigation for heritable and nonheritable causes of mismatch repair deficient colorectal cancer to identify Lynch syndrome.
    Vos JR; Fakkert IE; Spruijt L; Willems RW; Langenveld S; Mensenkamp AR; Leter EM; Nagtegaal ID; Ligtenberg MJL; Hoogerbrugge N;
    Int J Cancer; 2020 Oct; 147(8):2150-2158. PubMed ID: 32510614
    [TBL] [Abstract][Full Text] [Related]  

  • 50. From Genetics to Histomolecular Characterization: An Insight into Colorectal Carcinogenesis in Lynch Syndrome.
    Lepore Signorile M; Disciglio V; Di Carlo G; Pisani A; Simone C; Ingravallo G
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201893
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multivitamin, calcium and folic acid supplements and the risk of colorectal cancer in Lynch syndrome.
    Chau R; Dashti SG; Ait Ouakrim D; Buchanan DD; Clendenning M; Rosty C; Winship IM; Young JP; Giles GG; Macrae FA; Boussioutas A; Parry S; Figueiredo JC; Levine AJ; Ahnen DJ; Casey G; Haile RW; Gallinger S; Le Marchand L; Thibodeau SN; Lindor NM; Newcomb PA; Potter JD; Baron JA; Hopper JL; Jenkins MA; Win AK
    Int J Epidemiol; 2016 Jun; 45(3):940-53. PubMed ID: 27063605
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pathology of the hereditary colorectal carcinoma.
    Gatalica Z; Torlakovic E
    Fam Cancer; 2008; 7(1):15-26. PubMed ID: 17564815
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of the colorectal cancer risk conferred by rare UNC5C alleles.
    Küry S; Garrec C; Airaud F; Breheret F; Guibert V; Frenard C; Jiao S; Bonneau D; Berthet P; Bossard C; Ingster O; Cauchin E; Bezieau S
    World J Gastroenterol; 2014 Jan; 20(1):204-13. PubMed ID: 24415873
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical and histomolecular endometrial tumor characterization of patients at-risk for Lynch syndrome in South of Brazil.
    Cossio SL; Koehler-Santos P; Pessini SA; Mónego H; Edelweiss MI; Meurer L; Errami A; Coffa J; Bock H; Saraiva-Pereira ML; Ashton-Prolla P; Prolla JC
    Fam Cancer; 2010 Jun; 9(2):131-9. PubMed ID: 19821155
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of mutator phenotype in familial colorectal cancer patients not fulfilling amsterdam criteria.
    Kim JC; Lee KH; Ka IH; Koo KH; Roh SA; Kim HC; Yu CS; Kim TW; Chang HM; Gong GY; Kim JS
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6159-68. PubMed ID: 15448003
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The First Molecular Screening of MLH1 and MSH2 Genes in Moroccan Colorectal Cancer Patients Shows a Relatively High Mutational Prevalence.
    Moufid FZ; Bouguenouch L; El Bouchikhi I; Chbani L; Iraqui Houssaini M; Sekal M; Belhassan K; Bennani B; Ouldim K
    Genet Test Mol Biomarkers; 2018 Aug; 22(8):492-497. PubMed ID: 30044143
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early-onset colorectal cancer is an easy and effective tool to identify retrospectively Lynch syndrome.
    Perea J; Rodríguez Y; Rueda D; Marín JC; Díaz-Tasende J; Álvaro E; Alegre C; Osorio I; Colina F; Lomas M; Hidalgo M; Benítez J; Urioste M
    Ann Surg Oncol; 2011 Nov; 18(12):3285-91. PubMed ID: 21590452
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.
    Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL
    J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population.
    Lagerstedt-Robinson K; Rohlin A; Aravidis C; Melin B; Nordling M; Stenmark-Askmalm M; Lindblom A; Nilbert M
    Oncol Rep; 2016 Nov; 36(5):2823-2835. PubMed ID: 27601186
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High-sensitivity microsatellite instability assessment for the detection of mismatch repair defects in normal tissue of biallelic germline mismatch repair mutation carriers.
    González-Acosta M; Marín F; Puliafito B; Bonifaci N; Fernández A; Navarro M; Salvador H; Balaguer F; Iglesias S; Velasco A; Grau Garces E; Moreno V; Gonzalez-Granado LI; Guerra-García P; Ayala R; Florkin B; Kratz C; Ripperger T; Rosenbaum T; Januszkiewicz-Lewandowska D; Azizi AA; Ragab I; Nathrath M; Pander HJ; Lobitz S; Suerink M; Dahan K; Imschweiler T; Demirsoy U; Brunet J; Lázaro C; Rueda D; Wimmer K; Capellá G; Pineda M
    J Med Genet; 2020 Apr; 57(4):269-273. PubMed ID: 31494577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.